Novo Nordisk's Pill, Orsted Winded, Pets At Home Up

On This episode of Stock Movers:

- Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly.

- Orsted said it’s considering “all options” including legal action as it weighs how to respond to a US decision to suspend leases for five offshore wind farms, according to a statement late Monday.

- Pets at Home Group named James Bailey, the former managing director of upmarket grocer Waitrose, as its new chief executive officer to lead a reboot of the struggling pet care company. 

See omnystudio.com/listener for privacy information.